NCT07842809

Brief Summary

This study compares three approaches to cataract surgery. Cataract surgery involves removing the eye's cloudy natural lens and replacing it with an artificial intraocular lens (IOL) to restore clear vision. IOLs are made from different materials, most commonly a "hydrophilic" (water-attracting) acrylic or a "hydrophobic" (water-repelling) acrylic. Hydrophilic lenses are generally easier and less expensive to use, but have been linked in past research to a higher chance of the lens capsule becoming cloudy again after surgery (posterior capsule opacification, or PCO), sometimes requiring a follow-up laser treatment. Hydrophobic lenses tend to have lower rates of this problem but can cost more. A capsular tension ring (CTR) is a small flexible ring that can be placed inside the eye at the time of surgery to help hold the lens capsule in a stable, round shape. This study asks whether adding a CTR when a hydrophilic lens is used can reduce the disadvantages usually seen with that lens material. 600 adult patients (ages 50-80) undergoing cataract surgery at three hospitals in Egypt were randomly assigned to one of three groups: (1) a hydrophilic lens plus a CTR, (2) a hydrophobic lens alone (the common comparison approach), or (3) a hydrophilic lens alone without a CTR. Patients were followed for 24 months, and researchers compared vision, glasses prescription accuracy, lens position, capsule clouding, need for laser treatment, and surgical complications between the groups. The results showed that adding a CTR to a hydrophilic lens produced results very similar to using a hydrophobic lens alone. In contrast, using a hydrophilic lens without a CTR resulted in worse vision, less accurate glasses prescriptions, more lens shifting or tilting, more capsule clouding, a higher need for laser treatment, and more complications compared with the hydrophobic lens. These findings suggest that adding a CTR may be a simple, low-cost way to improve outcomes when a hydrophilic lens is used for cataract surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2022

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 21, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 25, 2026

Completed
Last Updated

September 25, 2026

Status Verified

September 1, 2026

Enrollment Period

3.4 years

First QC Date

September 21, 2026

Last Update Submit

September 21, 2026

Conditions

Keywords

Capsular tension ringCataract surgeryPhacoemulsification

Outcome Measures

Primary Outcomes (1)

  • Best-corrected visual acuity (BCVA)

    Best-corrected visual acuity measured in logMAR units, assessed longitudinally at 1, 3, 6, 12, 18, and 24 months, with between-group comparison at 24 months as the primary efficacy endpoint.

    24 months postoperatively

Secondary Outcomes (1)

  • Manifest spherical equivalent refractive error

    24 months postoperatively

Study Arms (3)

U.S. flag An official website of the United States government Here's how you know Skip to main page

EXPERIMENTAL

Phacoemulsification with implantation of a hydrophilic acrylic intraocular lens (Eyecryl, Biotech Healthcare, India) combined with insertion of a polymethyl methacrylate capsular tension ring (Auroring CTR 11, Aurolab, India).

Device: Hydrophilic acrylic intraocular lens (Eyecryl)Device: Capsular tension ring (Auroring CTR 11)

Group B: Hydrophobic IOL alone

ACTIVE COMPARATOR

Phacoemulsification with implantation of a hydrophobic acrylic intraocular lens (AcrySof IQ, Alcon Laboratories, USA), without a capsular tension ring.

Device: Hydrophobic acrylic intraocular lens (AcrySof IQ)

Group C: Hydrophilic IOL alone

EXPERIMENTAL

Phacoemulsification with implantation of the same hydrophilic acrylic intraocular lens used in Group A (Eyecryl, Biotech Healthcare, India), without capsular tension ring insertion.

Device: Hydrophilic acrylic intraocular lens (Eyecryl)

Interventions

Foldable hydrophilic acrylic intraocular lens implanted in the capsular bag following phacoemulsification.

Group C: Hydrophilic IOL aloneU.S. flag An official website of the United States government Here's how you know Skip to main page

Polymethyl methacrylate capsular tension ring (overall diameter 13.0 mm, compressed diameter 11.0 mm) inserted into the capsular bag to distribute equatorial zonular forces and maintain capsular bag contour.

U.S. flag An official website of the United States government Here's how you know Skip to main page

Foldable hydrophobic acrylic intraocular lens implanted in the capsular bag following phacoemulsification.

Group B: Hydrophobic IOL alone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 50-80 years
  • Visually significant age-related cataract, defined as nuclear opacity grade \>=3 according to the Lens Opacities Classification System III (LOCS III), graded preoperatively under standardized mydriasis via slit-lamp biomicroscopy
  • Clear cornea
  • Adequate pupillary dilation
  • Anatomically normal capsular bag with no evidence of zonular weakness
  • No ocular comorbidities expected to affect visual or refractive outcomes

You may not qualify if:

  • Previous intraocular surgery
  • Ocular trauma
  • Pseudoexfoliation syndrome
  • Posterior polar cataract
  • Zonular instability
  • Complicated cataract
  • Active intraocular inflammation
  • Retinal or optic nerve pathology
  • Anticipated need for additional capsular support devices beyond the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Benha University

Banhā, Benha, 13111, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors and data analysts were blinded to treatment allocation. Operating surgeons could not be masked due to the nature of the surgical intervention (visible IOL material and presence/absence of a capsular tension ring during implantation).
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Three-arm, parallel-group, randomized controlled trial comparing hydrophilic acrylic IOL plus capsular tension ring, hydrophobic acrylic IOL alone, and hydrophilic acrylic IOL alone.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Ophthalmology

Study Record Dates

First Submitted

September 21, 2026

First Posted

September 25, 2026

Study Start

December 15, 2022

Primary Completion

May 15, 2026

Study Completion

May 15, 2026

Last Updated

September 25, 2026

Record last verified: 2026-09

Locations